Vertex Pharmaceuticals (Germany) Probability of Future Stock Price Finishing Under 427.56
| VX1 Stock | EUR 429.45 5.60 1.32% |
Vertex |
Vertex Pharmaceuticals Target Price Odds to finish below 427.56
The tendency of Vertex Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to € 427.56 or more in 90 days |
| 429.45 | 90 days | 427.56 | about 31.65 |
Based on a normal probability distribution, the odds of Vertex Pharmaceuticals to drop to € 427.56 or more in 90 days from now is about 31.65 (This Vertex Pharmaceuticals Incorporated probability density function shows the probability of Vertex Stock to fall within a particular range of prices over 90 days) . Probability of Vertex Pharmaceuticals price to stay between € 427.56 and its current price of €429.45 at the end of the 90-day period is nearly 4.23 .
Assuming the 90 days horizon Vertex Pharmaceuticals has a beta of 0.52. This entails as returns on the market go up, Vertex Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Vertex Pharmaceuticals Incorporated will be expected to be much smaller as well. Additionally Vertex Pharmaceuticals Incorporated has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Vertex Pharmaceuticals Price Density |
| Price |
Predictive Modules for Vertex Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vertex Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Vertex Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Vertex Pharmaceuticals is not an exception. The market had few large corrections towards the Vertex Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Vertex Pharmaceuticals Incorporated, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Vertex Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.07 | |
β | Beta against Dow Jones | 0.52 | |
σ | Overall volatility | 16.35 | |
Ir | Information ratio | -0.07 |
Vertex Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vertex Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vertex Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Over 96.0% of the company outstanding shares are owned by institutional investors |
Vertex Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vertex Stock often depends not only on the future outlook of the current and potential Vertex Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vertex Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 257 M |
Vertex Pharmaceuticals Technical Analysis
Vertex Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Vertex Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Vertex Pharmaceuticals Incorporated. In general, you should focus on analyzing Vertex Stock price patterns and their correlations with different microeconomic environments and drivers.
Vertex Pharmaceuticals Predictive Forecast Models
Vertex Pharmaceuticals' time-series forecasting models is one of many Vertex Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Vertex Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Vertex Pharmaceuticals
Checking the ongoing alerts about Vertex Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Vertex Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Over 96.0% of the company outstanding shares are owned by institutional investors |
Other Information on Investing in Vertex Stock
Vertex Pharmaceuticals financial ratios help investors to determine whether Vertex Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vertex with respect to the benefits of owning Vertex Pharmaceuticals security.